[Risk factors for adverse effects of drugs: more research is necessary].

Abstract

When drugs are registered, relatively little is known about their adverse effects as clinical trials generally include only small numbers of patients and are of limited duration. New European legislation and the monitoring of adverse events are intended to enable the timely recognition of adverse effects of newly-registered drugs. However, many adverse… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.